SAAVY Trademark

Trademark Overview


On Friday, February 5, 2021, a trademark application was filed for SAAVY with the United States Patent and Trademark Office. The USPTO has given the SAAVY trademark a serial number of 90513988. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, June 26, 2023. This trademark is owned by LogicBio Therapeutics, Inc.. The SAAVY trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

Pharmaceutical preparations for gene therapy and gene editing; drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; viral vectors, non-viral vectors, gene therapy vectors all for medical purposes in gene therapy; biotechnological platform technology, namely, biological nanoparticles for gene delivery to biological cells that includes adeno-associated viral (AAV) vectors to provide a platform for specific expression of biologics with therapeutic effect in gene therapy; drug delivery agents consisting of compounds comprised of proteins in the form of capsids and particles that facilitate the delivery of a wide range of pharmaceuticals; drug delivery agents, in the form of injectable solutions, intravenous fluids, intracerebral solutions, intrathecal solutions, intracisternal solutions, intraocular solutions, intranasal solutions, intratracheal solutions, intraarterial solutions, intramuscular solutions, and medicinal infusions in that ...

medical and scientific research in the fields of gene therapy and gene editing; pharmaceutical research services; pharmaceutical drug development services; custom development of biochemical reagents and biological nanoparticles, namely, therapeutic compositions that feature adeno-associated viral (AAV) vectors to provide a platform for specific expression of biologics with therapeutic effect in gene therapy
saavy

General Information


Serial Number90513988
Word MarkSAAVY
Filing DateFriday, February 5, 2021
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, June 26, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 29, 2022

Trademark Statements


Goods and ServicesPharmaceutical preparations for gene therapy and gene editing; drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; viral vectors, non-viral vectors, gene therapy vectors all for medical purposes in gene therapy; biotechnological platform technology, namely, biological nanoparticles for gene delivery to biological cells that includes adeno-associated viral (AAV) vectors to provide a platform for specific expression of biologics with therapeutic effect in gene therapy; drug delivery agents consisting of compounds comprised of proteins in the form of capsids and particles that facilitate the delivery of a wide range of pharmaceuticals; drug delivery agents, in the form of injectable solutions, intravenous fluids, intracerebral solutions, intrathecal solutions, intracisternal solutions, intraocular solutions, intranasal solutions, intratracheal solutions, intraarterial solutions, intramuscular solutions, and medicinal infusions in that facilitate the delivery of capsids and particles used for delivery of gene therapy
Pseudo MarkSAVVY
Goods and Servicesmedical and scientific research in the fields of gene therapy and gene editing; pharmaceutical research services; pharmaceutical drug development services; custom development of biochemical reagents and biological nanoparticles, namely, therapeutic compositions that feature adeno-associated viral (AAV) vectors to provide a platform for specific expression of biologics with therapeutic effect in gene therapy

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, May 11, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, May 11, 2021
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameLogicBio Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressLexington, MA 02421

Party NameLogicBio Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressLexington, MA 02421

Trademark Events


Event DateEvent Description
Thursday, August 3, 2023TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Thursday, August 3, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, August 3, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, August 3, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, August 3, 2023APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Thursday, August 3, 2023TEAS CHANGE OF OWNER ADDRESS RECEIVED
Monday, June 26, 2023ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, June 26, 2023ABANDONMENT - NO USE STATEMENT FILED
Tuesday, November 22, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, November 18, 2022SOU EXTENSION 1 GRANTED
Friday, November 18, 2022SOU EXTENSION 1 FILED
Friday, November 18, 2022TEAS EXTENSION RECEIVED
Tuesday, May 24, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, March 29, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 29, 2022PUBLISHED FOR OPPOSITION
Wednesday, March 9, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Sunday, February 20, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Sunday, February 20, 2022EXAMINER'S AMENDMENT ENTERED
Sunday, February 20, 2022NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Sunday, February 20, 2022EXAMINERS AMENDMENT E-MAILED
Sunday, February 20, 2022EXAMINERS AMENDMENT -WRITTEN
Sunday, February 20, 2022PREVIOUS ALLOWANCE COUNT WITHDRAWN
Saturday, February 19, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, January 20, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, January 20, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, January 20, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, August 30, 2021NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, August 30, 2021NON-FINAL ACTION E-MAILED
Monday, August 30, 2021NON-FINAL ACTION WRITTEN
Sunday, August 29, 2021ASSIGNED TO EXAMINER
Tuesday, May 11, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, February 9, 2021NEW APPLICATION ENTERED